Login / Signup

Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease.

Duygu TosunOzlem YardibiTammie L S BenzingerWalter A KukullColin L MastersRichard J PerrinMichael W WeinerArthur SimenAdam J Schwarznull null
Published in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2023)
Our results lead to a better understanding of the factors that influence cognitive decline and may lead to improvements in AD clinical trial design.
Keyphrases
  • cognitive decline
  • clinical trial
  • mild cognitive impairment
  • phase ii
  • open label
  • phase iii
  • study protocol
  • double blind
  • amyotrophic lateral sclerosis
  • placebo controlled